UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000021488 |
|---|---|
| Receipt number | R000024783 |
| Scientific Title | Randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M1 occlusion - A prospective, multicenter, randomized trial |
| Date of disclosure of the study information | 2016/04/01 |
| Last modified on | 2021/09/21 13:25:15 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/03/16 01:59:17 | ||
| 2 | Update | 2017/10/03 15:27:47 | Public title |
|
| 3 | Update | 2017/10/03 15:45:48 | Classification by specialty Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 4 | Update | 2017/10/03 16:01:29 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 5 | Update | 2017/10/03 16:16:38 | Name of primary person or sponsor Institute Organization Organization |
|
| 6 | Update | 2017/10/03 16:20:06 | Recruitment status Anticipated trial start date |
|
| 7 | Update | 2018/09/19 15:52:54 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 8 | Update | 2019/09/18 10:38:22 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Zip code Last name of contact person Last name of contact person Zip code Division name Name of primary person or sponsor Organization Organization Address Address Tel |
|
| 9 | Update | 2019/09/18 10:44:23 | Recruitment status Date of IRB Last follow-up date |
|
| 10 | Update | 2021/09/21 13:22:58 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 11 | Update | 2021/09/21 13:24:33 | Recruitment status Date trial data considered complete |
|
| 12 | Update | 2021/09/21 13:25:15 | Publication of results |
